- Home
- YMM vs RVMD Comparison
YMM vs RVMD Comparison
Compare YMM & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMM
- RVMD
- Stock Information
- Founded
- YMM 2011
- RVMD 2014
- Country
- YMM China
- RVMD United States
- Employees
- YMM N/A
- RVMD N/A
- Industry
- YMM Computer Software: Prepackaged Software
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YMM Technology
- RVMD Health Care
- Exchange
- YMM Nasdaq
- RVMD Nasdaq
- Market Cap
- YMM 10.7B
- RVMD 8.7B
- IPO Year
- YMM 2021
- RVMD 2020
- Fundamental
- Price
- YMM $10.95
- RVMD $45.14
- Analyst Decision
- YMM Buy
- RVMD Strong Buy
- Analyst Count
- YMM 3
- RVMD 13
- Target Price
- YMM $11.67
- RVMD $62.77
- AVG Volume (30 Days)
- YMM 13.4M
- RVMD 2.0M
- Earning Date
- YMM 11-20-2024
- RVMD 11-06-2024
- Dividend Yield
- YMM 1.33%
- RVMD N/A
- EPS Growth
- YMM 62.58
- RVMD N/A
- EPS
- YMM 0.40
- RVMD N/A
- Revenue
- YMM $1,492,956,160.00
- RVMD $742,000.00
- Revenue This Year
- YMM N/A
- RVMD N/A
- Revenue Next Year
- YMM $18.69
- RVMD $1,855.42
- P/E Ratio
- YMM $26.48
- RVMD N/A
- Revenue Growth
- YMM 31.72
- RVMD N/A
- 52 Week Low
- YMM $5.70
- RVMD $25.60
- 52 Week High
- YMM $12.47
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- YMM 57.83
- RVMD 30.77
- Support Level
- YMM $10.39
- RVMD $44.46
- Resistance Level
- YMM $12.47
- RVMD $46.15
- Average True Range (ATR)
- YMM 0.40
- RVMD 2.05
- MACD
- YMM -0.03
- RVMD -0.71
- Stochastic Oscillator
- YMM 40.60
- RVMD 3.93
About YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.